Clinical trial
Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected…
NCT00046267 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00046267 |
|---|---|
| Title | Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients |
| Official title | A Pilot Study of the Safety, Efficacy, and Tolerability of Extended-Release Niacin (Niaspan) for the Treatment of Elevated Non-HDL Cholesterol and Elevated Triglycerides in HIV-Infected Subjects |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, Hypercholesterolemia, Hypertriglyceridemia, Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Niacin |
| Enrollment | 30 |
| Primary completion | Dec 1, 2006 |
| First posted | Sep 25, 2002 |
| Last update posted | Mar 2, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: